API
Bepotastine besilate
KDMF APIs
Bepotastine besilate
Korean name | 베포타스틴베실산염 |
|---|---|
Category | Allergy |
CAS No. | 125602-71-3 |
KDMF registration No. | 20190926-209-J-357 |
Manufacturer | Bal Pharma Limited |
Specification | JP |
Product information
IUPAC Name | 4-{4-[(4-chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic acid |
|---|---|
Description | Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. Bepotastine was approved in Japan for use in the treatment of allergic rhinitis and uriticaria/puritus in July 2000 and January 2002, respectively, and is marketed by Tanabe Seiyaku Co., Ltd. under the brand name Talion. It is available in oral and opthalmic dosage forms in Japan. The opthalmic solution is FDA approved since Sept 8, 2009 and is under the brand name Bepreve. |
Certificate of Analysis | If you need more information, please contact us. |
If you need additional documents such as specifications or certificates of analysis, please request them together with your inquiry. Our team will review and reply. (02-579-1056 · ace@acebiopharm.com)